Imperial line by NTC: Innovation for Your Eyes and the Oceans

With NTC’s new Imperial line of preservative-free eye drops, caring for your eyes also mean caring for the oceans.
The Imperial line combines cutting-edge ophthalmic technology with a deep commitment to sustainability. Thanks to the new dispensing system, the products of the Imperial line ensure precise dosing, drop after drop, until the end of the soft bottle, and improved patient compliance – all while being preservative-free.

“We improve our innovative dry eye portfolio, pursuing maximum patient satisfaction and compliance”, says Marcello Selvaggio, NTC Global Head Ophthalmology. “We launched the Imperial product line for dry eye, offering to our partners a solution that blends the benefits of the other main multidose preservative free devices into one, the Imperial product line, based on our innovative product range”.

But that’s not all.

For every Imperial bottle sold, NTC will collect an equivalent weight of plastic from the ocean in partnership with Ogyre, a global organization dedicated to cleaning marine environments and supporting fishing communities worldwide.

Up to now, 10,300 bottles have been extracted, and they symbolize NTC’s commitment to collecting 103 kg of marine litter.
Our Imperial line is 'plastic circular': companies worldwide are not only providing patients with a comprehensive range of hyaluronic acid-based formulations but are also playing an active role in combating oceans’ plastic pollution.
"Imperial by NTC: on the patient’s side, on the planet’s side”.

About NTC

A pharmaceutical company headquartered in Milan - Italy, with distributors and partners in more than 100 countries, engaged in research, development, registration, and commercialization of drugs, medical devices, and food supplements in ophthalmology, and other therapeutic areas including pediatrics, gynecology, and gastroenterology. NTC offers more than 200 partners innovative and high-quality standard pharmaceutical products. For more information, please visit www.ntcpharma.com